At baseline, in patients with treatment-naive RA, IFNγ-induced lymphocyte pSTAT1 and IL-4-induced monocyte pSTAT6 levels were higher in patients who achieved a good response to therapy than in non-responders to bDMARDS (38). Here, IL4 is linked to rheumatoid arthritis.